Here are five quick facts:
1. Tenet’s 52-week high is $60.93.
2. The company has a 52-week low of $21.39.
3. Tenet has a market cap of $2.75 billion.
4. During the first quarter of 2016, the company had generated adjusted EBITDA reaching $613 million.
5. As of March 31, 2016, Tenet had cash and cash equivalents of $728 million, up from $356 million at Dec. 31, 2015.
More articles on surgery centers:
27 key points on AmSurg, Nobilis, SCA, & Tenet’s Q1: Which ASC giant came out on top?
Frontier Healthcare Partners teams up with local physicians on Mulberry ASC: 6 takeaways
Amsurg stock receives ‘buy’ rating by Mizuho analysts: 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
